Noble launches AdhereIT platform for self-injection training

Noble this week launched its connected device platform, AdhereIT, to provide people that use auto-injectors with real-time feedback regarding their injection.

Users can attach the AdhereIT system to an auto-injector training device or a commercial product, Noble reported. The platform can detect when the auto-injector makes contact with a user’s skin and the time when an injection starts and ends.

AdhereIT also sends notifications via an app to remind users to practice their injections or when it’s time for them to use their prescribed devices. The system wirelessly transmits real-time feedback to the user, helping them to identify potential administration errors.

AdhereIT can be adapted to an array of commercial auto-injectors, according to Noble.

“There has been a rapid growth of innovative treatments delivered through autoinjectors, which allow patients the convenience of self-administering the drug. Our priority is to help ensure that patients who self-inject feel confident they are using their devices correctly, since studies suggest device familiarity and patient confidence may help improve adherence,” Noble CEO Jeff Baker said in prepared remarks. “We believe our new connected error correcting device platform, with its array of smart features, can coach patients through training to administration at home.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW